<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04018157</url>
  </required_header>
  <id_info>
    <org_study_id>5452</org_study_id>
    <nct_id>NCT04018157</nct_id>
  </id_info>
  <brief_title>Single Bolus Dose of Ketodex Versus Ketofol For Prevention Of Emergence Agitation In Adults Undergoing Nasal Surgeries</brief_title>
  <official_title>Single Bolus Dose of Ketodex Versus Ketofol For Prevention Of Emergence Agitation In Adults Undergoing Nasal Surgeries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zagazig University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zagazig University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  emergence agitation is seen in around 68% after nasal surgeries. Agitated patients needs&#xD;
           more staff and nurses to control their abnormal movement which leads to self extubation&#xD;
           , removal of catheters and bruises in the extremities.&#xD;
&#xD;
        -  Dexmedetomidine, ketamine, propofol intravenous infusion and other agents was used to&#xD;
           prevent EA . Recently, ketodex is found to reduce the incidence and severity of EA .&#xD;
&#xD;
        -  We aim to compare single bolus dose of Ketodex Versus Ketofol For Prevention Of&#xD;
           emergence Agitation in adults undergoing nasal surgeries.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The incidence of emergence agitation (EA) after nasal surgeries is relatively high , it is&#xD;
      reported to be 68% (1).The precise mechanism is not known. Awake extubation after nasal&#xD;
      surgeries is preferred as the airway may be contaminated by blood , and the nasal airway may&#xD;
      be blocked by surgical packs that causes sense of suffocation. Awake extubation and nasal&#xD;
      pack is a trigger to emergence agitation(2).&#xD;
&#xD;
      emergence agitation (EA) is harmful to the patient and the staff, it Characterized by&#xD;
      disorientation, confusion, abnormal violent movement that may result in serious complication&#xD;
      and morbidity(3). It develops early with the recovery from general anesthesia(4). Although&#xD;
      agitation is more observed in pediatrics but its incidence in adults reach up to 21.4% (5).&#xD;
&#xD;
      Different medication agents such as anesthetic drugs, benzodiazepine and α2 agonist was&#xD;
      proved to attenuate the EA with different efficiencies (6).&#xD;
&#xD;
      Dexmedetomidine is a selective α2 adrenoceptor agonist. It has sedative, hypnotic,&#xD;
      anxiolytic, analgesic and sympatholytic properties. It was proved to reduce the EA in&#xD;
      children(7). However there was few data about its effect in reducing the agitation in adult&#xD;
      after general anesthesia(8).&#xD;
&#xD;
      Propofol is short acting hypnotic and sedative agent. It is used for induction and&#xD;
      maintenance of anesthesia(9). Previous studies proved that propofol was effective in&#xD;
      preventing EA (10,11) and depends on the time of administration(12).&#xD;
&#xD;
      Ketamine is N-methyl- D-asparate receptor antagonist, it has anesthetic, sedative and&#xD;
      analgesic effect(13).&#xD;
&#xD;
      Ketofol is a combination of low dose ketamine with propofol , it has been used for sedation&#xD;
      and analgesia. The effect of this combination was supposed to produce less toxicity compared&#xD;
      to each drug alone by decreasing the required doses(14).&#xD;
&#xD;
      Ketodex is combined low dose of ketamine and dexmedetomidine, it was used for sedation , this&#xD;
      combination decrease some of the pitfalls occurring when use dexmedetomidine as a sole&#xD;
      agent(15).&#xD;
&#xD;
      Most EA studies was done in pediatric. To our knowledge there was no previous studies report&#xD;
      the effect of bolus dose of ketodex versus ketofol on the incidence and prevention of EA&#xD;
      after nasal surgeries in adults. This study aimed to compare single bolus dose of Ketodex&#xD;
      Versus Ketofol For Prevention Of Emergence Agitation In adults Undergoing nasal surgeries.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 3, 2019</start_date>
  <completion_date type="Actual">November 23, 2019</completion_date>
  <primary_completion_date type="Actual">November 20, 2019</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>patient and outcomes assessor</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of emergence agitation.</measure>
    <time_frame>up to 60 minutes after extubation</time_frame>
    <description>The incidence of emergence agitation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The level of emergence agitation.</measure>
    <time_frame>up to 60 minutes after extubation</time_frame>
    <description>The level of emergence agitation measured by . Richmond Agitation-Sedation scale (RASS) is ten scales; five for sedation level ,one for alertness and calmness, and four for agitation level as follow: -5 unarousable , -4 deep sedation , -3 moderate sedation , -2 light sedation , -1 drowsy ; 0 alert and calm,+1 restless , +2 agitated , +3 very agitated and +4 combative. Patients with score ≥ 2 considered having agitation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Emergence time</measure>
    <time_frame>up to 20 minutes after discontinuation of isoflurane</time_frame>
    <description>The time from discontinuation of isoflurane to first response to verbal command.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The extubation time</measure>
    <time_frame>up to 20 minutes after discontinuation of isoflurane</time_frame>
    <description>time from discontinuation of isoflurane to extubation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The time of discharge</measure>
    <time_frame>up to 40 minutes after extubation</time_frame>
    <description>The time from arrival to postanesthesia care unite (PACU) to discharge to the ward according to modified aldert score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Pain is evaluated using Numerical rating Scale (NRS)</measure>
    <time_frame>up to 40 minutes after extubation</time_frame>
    <description>(NRS) A commonly used scale is a 10-cm line labeled with &quot;worst pain imaginable&quot; on the right border and &quot;no pain&quot; on the left border.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>&quot;Number of Participants with vomiting or hypotension or bradycardia&quot;</measure>
    <time_frame>all over 40 minutes post-operative</time_frame>
    <description>vomiting , hypotension, bradycardia Vomiting</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Agitation, Emergence</condition>
  <arm_group>
    <arm_group_label>ketodex</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ketamine dexmedetomidine mixture</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ketofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ketamine propofol mixture</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>normal saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>&quot;Ketamine&quot; and &quot;dexmedetomidine&quot; and &quot;propofol&quot; and &quot;0.9%saline&quot;</intervention_name>
    <description>patients will receive single intravenous bolus of combination from ketamine 0.5mg/kg and dexmedetomidine 1ug/kg in one syringe diluted in 10 ml 0.9% saline.</description>
    <arm_group_label>ketodex</arm_group_label>
    <arm_group_label>ketofol</arm_group_label>
    <arm_group_label>placebo</arm_group_label>
    <other_name>ketalar</other_name>
    <other_name>precedex</other_name>
    <other_name>diprivan</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient acceptance.&#xD;
&#xD;
               -  Both gender.&#xD;
&#xD;
               -  Age (21-60) years old.&#xD;
&#xD;
               -  patient with Body Mass Index (BMI) (25-35kg/m²).&#xD;
&#xD;
               -  American Society of Anesthesiologist (ASA) I / II&#xD;
&#xD;
               -  Adult patient scheduled to elective nasal surgeries&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  - Patient with difficult airway (mallampati III,IV).&#xD;
&#xD;
          -  Altered mental status (psychiatric and anxiety disorder).&#xD;
&#xD;
          -  Post traumatic stress disorders.&#xD;
&#xD;
          -  History of allergy to study drugs.&#xD;
&#xD;
          -  Patient on sedative or hypnotic medication.&#xD;
&#xD;
          -  Patients with chronic pain or on painkiller.&#xD;
&#xD;
          -  Patients with severe hepatic or kidney impairment.&#xD;
&#xD;
          -  Patients having a history of thyrotoxicosis, hypertension, cardiac , chest or&#xD;
             neurological disease.&#xD;
&#xD;
          -  Patient receiving B agonist.&#xD;
&#xD;
          -  Pregnant or breast feeding female.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olfat Amin, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of medicine, Zagazig university</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Medicine</name>
      <address>
        <city>Zagazig</city>
        <state>Elsharkia</state>
        <zip>022/055</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>July 4, 2019</study_first_submitted>
  <study_first_submitted_qc>July 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 12, 2019</study_first_posted>
  <last_update_submitted>November 25, 2019</last_update_submitted>
  <last_update_submitted_qc>November 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 27, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zagazig University</investigator_affiliation>
    <investigator_full_name>olfat abd elmoniem ibrahem</investigator_full_name>
    <investigator_title>principle investigator</investigator_title>
  </responsible_party>
  <keyword>ketodex, ketofol , agitation , nasal surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psychomotor Agitation</mesh_term>
    <mesh_term>Emergence Delirium</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

